Paper: Assessment of subcutaneous absorption of enoxaparin for deep vein thrombosis prophylaxis using anti-factor Xa level measurements in non-critically-ill mechanically-ventilated patients (2009 ACCP/ESCP International Congress on Clinical Pharmacy (April 24

Sunday, April 26, 2009

Angela O. Shogbon, Pharm.D. , Mercer University College of Pharmacy and Health Sciences, Decatur, GA

Steven B. Levy, Pharm.D., BCPS, CGP , Kingsbrook Jewish Medical Center, Brooklyn, NY

Wilfrid Herard, MD , Kingsbrook Jewish Medical Center, Brooklyn, NY

Maria Arias, RNC, BSN , Kingsbrook Jewish Medical Center, Brooklyn, NY

Henry Cohen, MS, Pharm.D., FCCM, BCPP, CGP , Arnold & Marie Schwartz College of Pharmacy and Health Sciences of Long Island University and Kingsbrook Jewish Medical Center, Brooklyn, NY

Copy and pasted html document 1.html (0.0KB) - Abstract

See more of: Scientific Poster Presentations #2
See more of: Late Breakers

<< Previous Abstract | Next Abstract >>

299 Assessment of subcutaneous absorption of enoxaparin for deep vein thrombosis prophylaxis using anti-factor Xa level measurements in non-critically-ill mechanically-ventilated patients